Retinoid X Receptor Ligands with Anti-Type 2 Diabetic Activity

E-ISSN： 1873-4294|17|6|696-707

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.17, Iss.6, 2017-01, pp. : 696-707

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retinoid X receptor ligands: a patent review (2007 – 2013)

By Yamada Shoya Kakuta Hiroki

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 4, 2014-04 ,pp. : 443-452

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes

By Kintscher U. Goetze S. Wakino S. Kim S. Nagpal S. Chandraratna R.A.S. Graf K. Fleck E. Hsueh W.A. Law R.E.

European Journal of Pharmacology, Vol. 401, Iss. 3, 2000-08 ,pp. : 259-270

Elsevier

Access to resources Recommend Favorite

Structure-Activity Relationships of Histamine H2 Receptor Ligands+

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 9, 2004-11 ,pp. : 941-954

Bentham Science Publishers

Access to resources Recommend Favorite

CB2 Receptor Ligands

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 7, 2005-07 ,pp. : 641-649

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of endothelial cell proliferation by retinoid x receptor agonists

By Pakala R. Benedict C.R.

European Journal of Pharmacology, Vol. 385, Iss. 2, 1999-12 ,pp. : 255-261

Elsevier

Access to resources Recommend Favorite